alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL DATA EXTRACTED FROM THE FINANCIAL
STATEMENTS OF STATE OF FRANKLIN BANCSHARES, INC. FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                      14,294,159
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 17,547,201
<INVESTMENTS-CARRYING>                         998,179
<INVESTMENTS-MARKET>                         1,000,081
<LOANS>                                     79,223,226
<ALLOWANCE>                                    568,231
<TOTAL-ASSETS>                             116,915,078
<DEPOSITS>                                  95,538,290
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                         10,171,719
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,128,495
<OTHER-SE>                                  10,076,574
<TOTAL-LIABILITIES-AND-EQUITY>             116,915,078
<INTEREST-LOAN>                              4,091,486
<INTEREST-INVEST>                            1,384,578
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                             5,476,064
<INTEREST-DEPOSIT>                           3,256,088
<INTEREST-EXPENSE>                           3,421,134
<INTEREST-INCOME-NET>                        1,841,896
<LOAN-LOSSES>                                  213,034
<SECURITIES-GAINS>                              38,769
<EXPENSE-OTHER>                              1,767,899
<INCOME-PRETAX>                                341,880
<INCOME-PRE-EXTRAORDINARY>                     341,880
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   222,311
<EPS-PRIMARY>                                      .20
<EPS-DILUTED>                                      .20
<YIELD-ACTUAL>                                    3.18
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               355,474
<CHARGE-OFFS>                                      277
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                              568,231
<ALLOWANCE-DOMESTIC>                           568,231
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
```
[Federal Register Volume 63, Number 149 (Tuesday, August 4, 1998)]
[Notices]
[Page 41583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20706]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 98N-0331]

Agency Information Collection Activities; Announcement of OMB 
Approval

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Medical Devices; FDAMA Third-Party 
Review'' has been approved by the Office of Management and Budget (OMB) 
under the Paperwork Reduction Act of 1995 (the PRA).

FOR FURTHER INFORMATION CONTACT:  Margaret R. Schlosburg, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.

SUPPLEMENTARY INFORMATION:  In the Federal Register of May 22, 1998 (63 
FR 28388), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 
section 3507 of the PRA (44 U.S.C. 3507). An agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number. 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0375. The approval expires on November 30, 1998.

    Dated: July 24, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-20706 Filed 8-3-98; 8:45 am]
BILLING CODE 4160-01-F
```
DEFENSE LOGISTICS AGENCY
TROOP SUPPORT
700 ROBBINS AVENUE
PHILADELPHIA, PENNSYLVANIA 19111-5092

NOTICE TO NAPA AND MPA HOLDERS
September 21, 2017
SUBJECT: Rescission of the Request for Disclosure Regarding Prohibited Ingredients Notice

This Notice relates to DLA Troop Support’s Request for Disclosure Regarding Prohibited
Ingredients Notice dated August 17, 2017. In response to the numerous questions and concerns
expressed by manufacturers and industry groups, DLA Troop Support has decided to rescind that
Notice. The Government will conduct additional market research to assess the impact and costs
associated if the ingredients addressed in that Notice were to be limited or removed.

As part of this market research, a Request for Information (RFI) will be issued to request
comments from industry regarding items containing the following ingredients:

- Monosodium Glutamate (MSG) (as an added ingredient)

- Trans Fats (as an added ingredient)

- Partially Hydrogenated Fats

- Hemp Seeds

- Meat Protein Extenders such as, but not limited to, Textured Vegetable Protein
(TVP), Isolated Soybean Protein (ISP), Soy Protein Concentrate (SPC), Vegetable
Protein Product (VPP).

The purpose of the RFI will be to provide an opportunity for manufacturers and industry
groups to submit their specific concerns regarding the removal of these ingredients from food
items supplied to the military. The information submitted will assist the Government in
understanding the impact on industry, as well as the costs and benefits to the Government, with
the proposed restrictions.

The Government will release the RFI publicly, and may use the Federal Register and/or
the Federal Business Opportunities (FedBizOpps) to do so.

Please direct any questions or concerns about this Notice to Janine Samoni at 215-737-
2999, or Janine.Samoni@dla.mil.

HAL Au mow

JANINE SAMONI
Chief, SMSG Division
DLA Troop Support Subsistence
Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


National Immunization Surveys (NIS)


Section Navigation
			
			CDC Home


Facebook
        Twitter
        LinkedIn
        Syndicate





National Immunization Surveys (NIS) Methods										Related Pages
										Statistical Methodology of the National Immunization Survey, 2005–2014 pdf icon
Programs and Collection Procedures
Papers and Publications for the National Immunization Surveys
Includes reports on NIS methodology, sample design, data collection, and estimation and weighting.
							
					
						Page last reviewed:  December 15, 2017					Content source: 	National Center for Immunization and Respiratory Diseases, Immunization Services Division NIS Home
About NIS
For Participants
Frequently Asked Questions
For Health Care Professionals
Frequently Asked Questions
Data, Tables, and Documentation
NIS-Child Data and Documentation for 2015 to Present
NIS-Teen Data and Documentation for 2015 to Present
Methods
Publications and Resources
Confidentiality


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue
Order entered July 9, 2013

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-13-00442-CR

ROCKY MORRIS, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 291st Judicial District Court

Dallas County, Texas

Trial Court Cause No. F95-01315-U

ORDER

This appeal follows the trial court’s findings pursuant to article 64.04 of the Texas Code 

of Criminal Procedure regarding the results of the post-conviction DNA testing conducted in the 

case. The clerk’s record has been filed, but no reporter’s record has been filed.

Accordingly, the Court ORDERS Peri Stromberg, official court reporter of the 291st 

Judicial District Court to file, within THIRTY DAYS of the date of this order, either the 

reporter’s record or written verification that no hearings were conducted regarding appellant’s 

motion for post-conviction DNA testing.

We ORDER appellant to file his brief within SIXTY DAYS of the date of this order. 
We DIRECT the Clerk to send copies of this order, by electronic transmission, to Peri 

Stromberg, Official Court Reporter, 291st Judicial District Court, and to Michael Casillas, Dallas 

County District Attorney’s Office.

We DIRECT the Clerk to send a copy of this order, by first-class mail, to Rocky Morris, 

No. 12076456, Dallas County Jail, P.O. Box 660334, Dallas, TX 75266-0334.

/s/ CAROLYN WRIGHT

CHIEF JUSTICE
Notice: This opinion is subject to formal revision before publication in the Atlantic

and Maryland Reporters. Users are requested to notify the Clerk of the Court of any formal errors so that corrections may be made before the bound volumes go

to press.

DISTRICT OF COLUMBIA COURT OF APPEALS

No. 2 1

- BG

- 19 8

IN RE BARRY N. FRANK

20 19 D DN 194

A n Administratively Suspended Member

of the Bar of the District of Columbia Court of Appeals

Bar Reg istration . No. 371252

BEFORE: Glickman and McLeese

, Associate Judge s , and Fisher , Senior J udge

.

O R D E R
(FILED

– June 17, 2021)

On consideration of the certified order from the state of New York accepting respondent’s resignation from the practice of law while he was under disciplinary investigation; this court’s April 15, 2021

, order suspending respondent pending

resolution of t his matter and directing h im to show cause why the functional reciprocal discipline of disbarment should not be imposed; the sta tement of Disciplinary Counsel ; and it appearing that respondent failed to file a response to
this court’s order to show cause or his D.C. Bar R. XI, §14 (g) affidavit

, it is

ORDERED that Barry N. Frank is hereby disbarred from the practice of law

in the District of Columbia

. See In re Sibley , 990 A.2d 483 (D.C. 2010) ; In re Fuller

, 930 A.2d 194, 198 (D.C. 2007) (rebuttable presumption of identical reciprocal discipline applies to all cases in which the respondent does not participate). It is

FURTHER ORDERED that for purposes of reinstatement respondent’s

disbarment will not begin to run until such time as he files an affidavit that fully complies with the requirements of D.C. Bar R. XI, § 14(g).

PER CURIAM
EX-10.9



 Exhibit 10.9 

COMMERCE UNION BANK AND COMMERCE UNION BANCSHARES, INC. 

FIRST AMENDMENT TO ORGANIZER STOCK OPTION AGREEMENT 

THIS FIRST AMENDMENT to that certain Organizer Stock Option Agreement (the “Agreement”) is made and entered into as of
the date set forth below, by and among Commerce Union Bank (the “Bank”), Commerce Union Bancshares, Inc. (the “Company”), and the optionee whose name appears below (the “Optionee”). 

WHEREAS, the Company and the Bank entered into that certain Agreement and Plan of Share Exchange (the “Share Exchange
Agreement”), dated April 26, 2011, pursuant to which, as of June 6, 2012, the Company assumed all responsibilities and obligations of the Bank with respect to all outstanding Bank Stock Options, as defined in the
Share Exchange Agreement; and 
 WHEREAS, the Company, the Bank, and the Optionee desire to amend the Agreement to further document
the assumption of the obligations by the Company to the Optionee; 
 NOW, THEREFORE, in consideration of the promises and mutual
covenants hereinafter set forth, the undersigned agree as follows: 
  

	 	1.	Except as provided herein, all of the provisions of the Agreement remain in full force and effect until such time as the expiration of the rights granted thereunder. 


 

	 	2.	From and after the Effective Time of the Plan of Share Exchange, the Bank Stock Options granted by the Bank pursuant to the Agreement and the Commerce Union Bank Stock Option Plan shall be exercisable only for Company
common stock pursuant to that certain Commerce Union Bancshares, Inc. Stock Option Plan. 

 IN WITNESS WHEREOF, the
Company, the Bank, and the Optionee have duly executed this First Amendment to the Organizer Stock Option Agreement, which shall be deemed effective as of the Effective Time of the Plan of Share Exchange. 

 

					
	COMMERCE UNION BANCSHARES, INC. and	 		 	OPTIONEE
	COMMERCE UNION BANK	 		 	
			
	  
	 		 	  

	William R. (Ron) DeBerry, President and CEO	 		 	(signature)
			
		 		 	  

		 		 	(print name)
Exhibit 32.2

CERTIFICATION

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United
States Code), the undersigned officer of Heidrick & Struggles International, Inc., a Delaware corporation (the Company), does hereby certify that:

The Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 (the Form 10-Q) of the Company fully complies with the requirements of section 13 (a) or 15 (d) of the Securities
Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                   |  |                                                                                   
|------------------ |  | ----------------------------------------------------------------------------------
|Dated: May 4, 2007 |  | /s/ Eileen A. Kamerick                                                            
|                   |  | Eileen A. Kamerick                                                                
|                   |  | Executive Vice President, Chief Financial Officer and Chief Administrative Officer
ID Descriptor L* a* b* c h dL* da* db* dEcmc*

Standard 18-04 STANDARD 78.64 -1.70 -13.77

Tolerance

1 1 RED LIMIT 78.20 -1.35 -13.87 -0.44 0.35 -0.10 0.40

2

3

4

5

6

7

8

9

COMMENTS: NUMBERS ARE FOR REFERENCE ONLY 

Equipment Type HUNTER ULTRA SCAN PRO Setting Mode: Specular Included - 

Reflectance

UV Filter – OUT UV Lamp OFF

Shade Number AF BLUE 1664 Piece/Roll Number 18-04

DLA/AIR FORCE SHADE TOLERANCE PROJECT February 3, 2022

Fabric Nomenclature 65% POLYESTER/35% COTTON, HERRINGBONE, YARN 

DYED, BROADCLOTH GL/PD 11-05
No. 11-5652.

#### Keith Marshel Ivers, Petitioner v. United States.

565 U.S. 917, 132 S. Ct. 337,

181 L. Ed. 2d 211,

2011 U.S. LEXIS 5766.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Same case below, 430 Fed. Appx. 573.
[Federal Register Volume 63, Number 146 (Thursday, July 30, 1998)]
[Notices]
[Page 40759]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20366]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-40197A; File No. SR-MSRB-98-04]


Self-Regulatory Organizations; Municipal Securities Rulemaking 
Board; Order Granting Approval of Proposed Rule Change Relating to Rule 
G-32, on Disclosures in Connection With New Issues

July 23, 1998.

Correction

    In FR Document No. 98-19445, beginning on page 39322 for Wednesday, 
July 22, 1998, the first full paragraph of the page is revised to read:
    The amendment provides an alternate method of compliance with Rule 
G-32 in the case of Exempt VRDOs where the final official statement is 
either unavailable or incomplete. The amendment is intended to provide 
relief to dealers in the event they do not receive the final official 
statement from the issuer with enough time to deliver the document to 
their customers by settlement. Therefore, in those limited 
circumstances where dealers may in fact receive the official statement 
in final form in sufficient time to deliver it to customers by 
settlement (e.g., if an issuer approves completion of the official 
statement in final form prior to execution of the purchase contract), 
dealers would have the option of complying with the existing provision 
of the rule by delivering the official statement in final form to the 
customer by settlement.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\1\
---------------------------------------------------------------------------

    \1\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Margaret H. McFarland,
Deputy Secretary.
[FR Doc. 98-20366 Filed 7-29-98; 8:45 am]
BILLING CODE 8010-01-M
No. 10-788.

#### Charles A. Rehberg, Petitioner v. James P. Paulk.

565 U.S. 940, 132 S. Ct. 445,

181 L. Ed. 2d 254,

2011 U.S. LEXIS 7330.

October 11, 2011.

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument denied.

Same case below, 611 F.3d 828.
Court of Appeals

of the State of Georgia

ATLANTA,____________________

The Court of Appeals hereby passes the following order:

A20A0235. DEBORAH BEACHAM v. CHARLES WAYNE BEACHAM.

Plaintiff Deborah Beacham filed an OCGA § 9-11-60 (d) motion to set aside

prior orders entered in proceedings related to her 2008 divorce and subsequent child

custody, child support, and contempt proceedings. Defendant Charles Beacham

moved to dismiss the § 9-11-60 (d) motion, and the plaintiff moved to strike the

defendant’s motion to dismiss. In a single order, the trial court denied the plaintiff’s

motion to strike and dismissed her § 9-11-60 (d) motion. The plaintiff then filed this

direct appeal. We lack jurisdiction.

An appeal from a trial court order in a domestic relations case must be initiated

by filing an application for discretionary review where a child custody ruling is not

at issue on appeal. Compare OCGA § 5-6-34 (a) (11), with id. § 5-6-35 (a) (2), (b);

accord Voyles v. Voyles, 301 Ga. 44, 47 (799 SE2d 160) (2017). An appeal from a

trial court order denying relief sought in a § 9-11-60 (d) motion to set aside likewise

must be initiated via an application for discretionary review. See OCGA § 5-6-35 (a)

(8), (b); Jim Ellis Atlanta, Inc. v. Adamson, 283 Ga. App. 116, 116 (640 SE2d 688)

(2006). “Compliance with the discretionary appeals procedure is jurisdictional.” 

Smoak v. Dept. of Human Resources, 221 Ga. App. 257, 257 (471 SE2d 60) (1996).

Here, the ruling sought to be appealed denied relief under § 9-11-60 (d) in a

domestic relations case and made no determination as to child custody. A

discretionary application therefore wasrequired to initiate this appeal. The plaintiff’s

failure to follow the proper procedure deprives us of jurisdiction over this direct

September 11, 2019
appeal, which is hereby DISMISSED. See Voyles, 301 Ga. at 47; Jim Ellis Atlanta,

Inc., 283 Ga. App. at 116-117.

Court of Appeals of the State of Georgia

Clerk’s Office, Atlanta,____________________

I certify that the above is a true extract from

the minutes of the Court of Appeals of Georgia.

Witness my signature and the seal of said court

hereto affixed the day and year last above written.

, Clerk.

09/11/2019
Ex-10.7



 Exhibit 10.7 
 Compensatory Arrangements for Non-Employee Directors 
 The Board of Directors of
MicroFinancial Incorporated (the “Company”) adopted the following annual compensation package for its non-employee directors, effective for fees and other compensation payable relating to the Company’s fiscal year ended
December 31, 2012 and, unless later amended, for subsequent periods: 
  

	 	•	 	 an annual retainer of $21,000, to be paid at the director’s election either entirely in shares of stock or 40% in cash and 60% in shares of stock,
in each case with full vesting upon the date of issuance; 


  

	 	•	 	 a cash fee of $1,250 for meetings, including committee meetings, not held by telephone and not held on the same day as a full Board meeting;



  

	 	•	 	 committee meeting fees of $500 for telephonic meetings and meetings on the same day as Board meetings; 



 

	 	•	 	 fees for the Chair of the Audit Committee ($10,500 per year), the Compensation and Benefits Committee ($5,250 per year) and the Nominating and
Governance Committee ($5,250 per year), to be paid either entirely in shares of stock or 40% in cash and 60% in shares of stock, in each case with full vesting upon the date of issuance; 



 

	 	•	 	 a fee for the Chairman of the Board of $10,500 per year, to be paid either entirely in shares of stock or 40% in cash and 60% in shares of stock, in
each case with full vesting upon the date of issuance; 


  

	 	•	 	 a stock grant made annually to each non-employee director valued at $44,100 on the date of grant, with all shares of stock fully vested upon the date
of issuance; and 


  

	 	•	 	 health insurance benefits for those non-employee directors who elect to participate, with the cost to be borne partially by the Company, consistent
with its past practices. 


 Committee chairs may decide in their discretion that a meeting is not substantive enough to merit
the committee fees described above.